My understanding is the peer review was delayed due to the reviewers being 100% allocated to COVID related reviews.
Nevertheless I'd like to understand new timeframes (that can and should naturally be highly qualified)
Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION, page-252
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 25.0¢ | 23.0¢ | $211.2K | 895.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 82174 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 49300 | 8 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |